Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPCORITAMAB for Follicular lymphoma stage iv: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 110 adverse event reports in the FDA FAERS database where EPCORITAMAB was used for Follicular lymphoma stage iv.

Most Reported Side Effects for EPCORITAMAB

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 551 27.0% 66 507
Pyrexia 258 12.6% 51 234
Off label use 229 11.2% 69 182
Febrile neutropenia 219 10.7% 19 216
Pneumonia 154 7.6% 38 138
Covid-19 125 6.1% 25 108
Sepsis 106 5.2% 46 95
Hypotension 95 4.7% 31 86
Diffuse large b-cell lymphoma 86 4.2% 46 15
Neutropenia 84 4.1% 24 66
Diarrhoea 83 4.1% 9 78
Disease progression 79 3.9% 42 36
Immune effector cell-associated neurotoxicity syndrome 78 3.8% 34 47
C-reactive protein increased 75 3.7% 2 74
Thrombocytopenia 68 3.3% 24 57

Other Indications for EPCORITAMAB

Diffuse large b-cell lymphoma (624) Follicular lymphoma (319) Diffuse large b-cell lymphoma stage iv (311) Product used for unknown indication (189) Diffuse large b-cell lymphoma stage iii (143) Diffuse large b-cell lymphoma stage ii (71) B-cell lymphoma (63) Diffuse large b-cell lymphoma stage i (59) Richter's syndrome (51) Follicular lymphoma stage iii (40)

Other Drugs Used for Follicular lymphoma stage iv

RITUXIMAB (281) BENDAMUSTINE (124) LENALIDOMIDE (120) CYCLOPHOSPHAMIDE (108) VINCRISTINE (100) DOXORUBICIN (93) PREDNISONE (74) OBINUTUZUMAB (70) PREDNISOLONE (34) ETOPOSIDE (33)

Related Pages

EPCORITAMAB Full Profile All Follicular lymphoma stage iv Drugs EPCORITAMAB Demographics EPCORITAMAB Timeline